Your browser doesn't support javascript.
loading
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer.
Freshour, Sharon L; Chen, Timothy H-P; Fisk, Bryan; Shen, Haolin; Mosior, Matthew; Skidmore, Zachary L; Fronick, Catrina; Bolzenius, Jennifer K; Griffith, Obi L; Arora, Vivek K; Griffith, Malachi.
Affiliation
  • Freshour SL; Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Chen TH; Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Fisk B; Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Shen H; McDonnell Genome Institute, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Mosior M; Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Skidmore ZL; Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Fronick C; McDonnell Genome Institute, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Bolzenius JK; Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Griffith OL; McDonnell Genome Institute, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Arora VK; McDonnell Genome Institute, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
  • Griffith M; Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
iScience ; 26(10): 107937, 2023 Oct 20.
Article de En | MEDLINE | ID: mdl-37810214
ABSTRACT
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse model of invasive urothelial carcinoma with three conditions untreated tumor, treated tumor, and tumor treated after CD4+ T cell depletion. After classifying tumor cells based on detection of somatic variants and assigning non-tumor cell types using SingleR, we performed differential expression analysis, overrepresentation analysis, and gene set enrichment analysis (GSEA) within each cell type. GSEA revealed that endothelial cells were enriched for upregulated IFN-g response genes when comparing treated cells to both untreated cells and cells treated after CD4+ T cell depletion. Functional analysis showed that knocking out IFNgR1 in endothelial cells inhibited treatment response. Together, these results indicated that IFN-g signaling in endothelial cells is a key mediator of ICB induced anti-tumor activity.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: IScience Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: IScience Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique